~~<i id='0660EAD63D'><strike id='0660EAD63D'><tt id='0660EAD63D'><pre id='0660EAD63D'></pre></tt></strike></i>~~

Home» Wikipedia» comprehensive

comprehensive

author：entertainment 2025-09-30 04:56:09 Page View：296

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Intercept Pharmaceuticals sells itself for less than $1 billion
Next article： Bright Health sells Medicare Advantage business to Molina

explore

Psychedelics group wrestles with new pharma identity

OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

After a drawn out lobbying fight, ARPA

Afteradrawn-outlobbyingfight,ARPA-Hchoseitsheadquarters:ahubandspokesmodel,withthreecentrallocations

Guidelines to prevent youth baseball injuries need more muscle

Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem

Intermittent fasting comes with a heart risk? Not so fast

AdobeThenewsiseverywhereinmysocialnewsfeedsthismorning:Apopularfaddietisapparentlylethal,scientificr